Opportunity Information: Apply for RFA DA 21 001

The National Institutes of Health (NIH) funding opportunity titled "Reducing Stigma Related to Drug Use in Human Service Settings (R34 Clinical Trial Required)" (Funding Opportunity Number: RFA-DA-21-001; CFDA: 93.279) is a discretionary grant program focused on tackling stigma as a major barrier to effective HIV prevention and HIV care. In this context, stigma is described as an identity marked by disgrace, disapproval, or shame, and it often shows up in real-world settings as discrimination, reduced quality of services, avoidance of care, or poorer engagement with prevention and treatment. The core problem the opportunity targets is that stigma related to drug use can directly interfere with whether people receive supportive services and whether they feel safe accessing HIV-related prevention and care in the first place, especially in human service environments where key interactions occur (for example, health and social service organizations and other frontline systems that interact with people who use drugs).

This opportunity specifically supports pilot or feasibility studies under the NIH R34 mechanism, meaning applicants are expected to propose early-stage research that tests whether an intervention is workable, acceptable, and promising enough to justify a later, larger-scale effectiveness trial. The emphasis is on developing and trying out new interventions or adapting existing interventions to reduce drug-use-related stigma in ways that improve the provision and utilization of HIV prevention and care services. Because it is labeled "Clinical Trial Required," the funded work is expected to include a clinical trial component, typically indicating a prospective study in which an intervention is assigned or implemented to evaluate its effects on outcomes relevant to stigma reduction and downstream impacts on HIV prevention and care engagement.

Eligibility is broad and includes many types of U.S.-based organizations and government entities. Applicants may include state, county, and city or township governments, special district governments, and independent school districts; public and state-controlled institutions of higher education as well as private institutions of higher education; federally recognized Native American tribal governments and other Native American tribal organizations (including those other than federally recognized tribal governments); public housing authorities and Indian housing authorities; nonprofit organizations both with and without 501(c)(3) IRS status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other eligible entities. The announcement also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); eligible federal agencies; faith-based or community-based organizations; regional organizations; Indian/Native American Tribal Governments other than federally recognized; and U.S. territories or possessions.

At the same time, there are important restrictions related to foreign involvement. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the primary applicant, and non-domestic components of U.S. organizations are also not eligible to apply. However, "foreign components" are allowed as defined by the NIH Grants Policy Statement, which generally means a U.S. applicant can include certain foreign activities or collaborations when justified and when they meet NIH policy requirements, even though the lead applicant organization itself must be eligible and domestic.

In terms of funding details, the listed award ceiling is $225,000, indicating the maximum funding level anticipated per award under this opportunity. The opportunity was created on April 9, 2020, and the original closing date was August 11, 2020. The overall activity category is identified as Education and Health, reflecting the program's combined focus on health outcomes (HIV prevention and care) and the training, systems, and service-delivery practices within human service settings that can either perpetuate or reduce stigma.

Taken together, this grant opportunity is aimed at generating practical, testable strategies to reduce drug-use-related stigma where it most directly affects people: in the settings that provide services, interact with clients, and influence whether individuals feel respected, safe, and willing to seek HIV prevention and treatment. The goal of the R34 pilot or feasibility scope is to produce strong preliminary evidence and implementation insight that can support future, larger research efforts and, ultimately, contribute to better HIV-related outcomes by removing stigma-driven barriers in real service environments.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Reducing Stigma Related to Drug Use in Human Service Settings (R34 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2020-04-09.
  • Applicants must submit their applications by 2020-08-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $225,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DA 21 001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Enhancing Agricultural Opportunities for Military Veterans Competitive Grants Program

Previous opportunity: D.4 University Leadership Initiative (ULI)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 21 001

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 21 001) also looked into and applied for these:

Funding Opportunity
Reducing Stigma Related to Drug Use in Human Service Settings (R21 Clinical Trial Optional) Apply for RFA DA 21 002

Funding Number: RFA DA 21 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional) Apply for PAR 20 170

Funding Number: PAR 20 170
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Apply for PA 20 172

Funding Number: PA 20 172
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) Apply for PAR 20 180

Funding Number: PAR 20 180
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) Apply for PAR 20 179

Funding Number: PAR 20 179
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Research Project Grant (Parent R01 Clinical Trial Required) Apply for PA 20 183

Funding Number: PA 20 183
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed) Apply for PAR 20 182

Funding Number: PAR 20 182
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,000,000
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) Apply for PA 20 190

Funding Number: PA 20 190
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) Apply for PA 20 208

Funding Number: PA 20 208
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed) Apply for RFA DA 21 019

Funding Number: RFA DA 21 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) Apply for PA 20 149

Funding Number: PA 20 149
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed) Apply for PA 20 151

Funding Number: PA 20 151
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) Apply for PAR 20 221

Funding Number: PAR 20 221
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 20 225

Funding Number: PAR 20 225
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional) Apply for PAR 20 224

Funding Number: PAR 20 224
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing HIV/AIDS Research through Computational Neuroscience FOA (R01 - Clinical Trial Optional) Apply for RFA DA 21 013

Funding Number: RFA DA 21 013
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) Apply for RFA CA 20 039

Funding Number: RFA CA 20 039
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) Apply for RFA CA 20 038

Funding Number: RFA CA 20 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional) Apply for RFA DA 21 009

Funding Number: RFA DA 21 009
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Regional Medical Libraries for the Network of the National Library of Medicine (UG4) Apply for RFA LM 20 001

Funding Number: RFA LM 20 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 21 001", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: